GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Porton Pharma Solutions Ltd (SZSE:300363) » Definitions » PB Ratio

Porton Pharma Solutions (SZSE:300363) PB Ratio : 1.46 (As of May. 28, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Porton Pharma Solutions PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-28), Porton Pharma Solutions's share price is ¥15.18. Porton Pharma Solutions's Book Value per Share for the quarter that ended in Mar. 2024 was ¥10.40. Hence, Porton Pharma Solutions's PB Ratio of today is 1.46.

Good Sign:

Porton Pharma Solutions Ltd stock PB Ratio (=1.47) is close to 10-year low of 1.38

The historical rank and industry rank for Porton Pharma Solutions's PB Ratio or its related term are showing as below:

SZSE:300363' s PB Ratio Range Over the Past 10 Years
Min: 1.38   Med: 5.82   Max: 20.75
Current: 1.46

During the past 13 years, Porton Pharma Solutions's highest PB Ratio was 20.75. The lowest was 1.38. And the median was 5.82.

SZSE:300363's PB Ratio is ranked better than
63.36% of 958 companies
in the Drug Manufacturers industry
Industry Median: 1.97 vs SZSE:300363: 1.46

During the past 12 months, Porton Pharma Solutions's average Book Value Per Share Growth Rate was -10.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 19.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 17.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 23.10% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Porton Pharma Solutions was 44.80% per year. The lowest was 11.20% per year. And the median was 25.40% per year.

Back to Basics: PB Ratio


Porton Pharma Solutions PB Ratio Historical Data

The historical data trend for Porton Pharma Solutions's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Porton Pharma Solutions PB Ratio Chart

Porton Pharma Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.53 5.84 12.23 3.72 2.37

Porton Pharma Solutions Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.20 2.76 2.59 2.37 1.72

Competitive Comparison of Porton Pharma Solutions's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Porton Pharma Solutions's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Porton Pharma Solutions's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Porton Pharma Solutions's PB Ratio distribution charts can be found below:

* The bar in red indicates where Porton Pharma Solutions's PB Ratio falls into.



Porton Pharma Solutions PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Porton Pharma Solutions's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=15.18/10.4
=1.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Porton Pharma Solutions  (SZSE:300363) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Porton Pharma Solutions PB Ratio Related Terms

Thank you for viewing the detailed overview of Porton Pharma Solutions's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Porton Pharma Solutions (SZSE:300363) Business Description

Traded in Other Exchanges
N/A
Address
Fangzheng Avenue, Porton New Drug Outsourcing Service and R&D Center, Shuitu, Beibei District, Chongqing, CHN, 400714
Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.
Executives
Wang Zhong Neng Executives
Yu Yong Mei Executives
Sun Min Executives
Ji Yao Hui Executives
Ju Nian Feng Directors, executives
Tan Jun Supervisors
Xu Ai Wu Directors, executives
Guo Yong Qing Independent director
Director
Director
Ceng Hui Supervisors
Chen Bei Executives

Porton Pharma Solutions (SZSE:300363) Headlines

No Headlines